Corcept tests psych. major depression Rx
13th Nov 2006, 19:47 GMT
Corcept Therapeutics said it has finished enrolling patients in its third phase 3 study of Corlux for treating psychotic major depression (PMD).
Corcept tests psych. major depression Rx related news:
- Corcept Tests Psych. Major Depression Rx — RedOrbit News - Health
- Corcept Therapeutics Completes Enrollment In Third Phase 3 Study For Treating Psychotic Major Depression — Health News from Medical News Today
- AmerisourceBergen tests Rx tracking plan — United Press International - Health Business
- Easing Depression Without a Prescription — iVillage Health & Well-Being News
- Breast Cancer Depression Common — WebMD Health Headlines
- Depression not anti-depressants leads to death — NewKerala Health News
- Caremark Rx to Present at the 2006 Credit Suisse Healthcare Conference — Pharmaceuticals News from StratCenter.com
- Health Integrated to Speak at World Research Group Summit on Disease Mgmt for Depression — Insurance/ Managed Care News from StratCenter.com
- Still Waiting for Personalized Medicine — Technology Review Feed - BioTech Top Stories
- Fishy answer to depression — NEWS.com.au | Breaking News
Latest news from United Press International - Health Business:
- AmerisourceBergen tests Rx tracking plan
- Lilly: Arxxant cuts sight loss in diabetes
- Merck: Arcoxia heart risk same as Voltaren
- Neurogen's obesity drug in phase 1 trial
- Analysis: Insurance horizons expanding
- Dendreon seeks OK for Provenge
- Robots caring for stroke patients
- Diabetes drug stalls heart disease
- Diabetes drug also helps arteries
- Promising vaccine for early breast cancer